Printer Friendly

NeuroTherm is awarded United States Patent for multi-lesion radiofrequency generator.

NeuroTherm (Wilmington, MA) was awarded a patent (United States Patent 7,574,257) for a multiple output radiofrequency generator used in the treatment of chronic pain.

"This patent is a great honor and represents a major step forward in radiofrequency technology," says Bill Rittman, CTO of NeuroTherm. "The multi-lesion design has since become the standard for the interventional pain industry; we have come a long way in helping patients who suffer from chronic pain and the people who treat them, and I look forward to being a part of many more innovations at NeuroTherm," continues Rittman.

"NeuroTherm is proud to receive this milestone patent which is one great example of the many novel technologies we have developed to treat those suffering with chronic pain," says Larry Hicks, CEO of NeuroTherm. "Protection of our intellectual property is also vital to maintaining our leadership," continues Hicks.

NeuroTherm was formed in September 2005, as a concurrent acquisition of RDG Medical in the U.K., and RF Medical and Precision Medical Engineering in the United States by Cortec Group, Inc. This merger brought together the worldwide known NeuroTherm brand name for generators with a United States leading disposables product line. NeuroTherm has a full line of RF generator and accessories, with several models offering the patented multi-level technology. NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain and Podiatry including the Micron Epidural catheters, NT line of radiofrequency generators, and related consumables. We focus on providing great products and a remarkable level of service so physicians are able to perform procedures more safely, quickly, and effectively.


COPYRIGHT 2009 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Aug 1, 2009
Previous Article:Brinks Hofer Gilson & Lione wins patent appeal for Cook Incorporated Federal Circuit holds that Cook's Endovascular graft devices do not infringe.
Next Article:Appeals Court affirms patent infringement rulings against Roche's peg-EPO product.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters